1. Kasper DL. Harrison's principels of internal medicine. 16th ed. New york:McGraw- Hill medical publishing division; 2005.
2. World Health Organization. Traditional medicine growing needs and potential. Geneva: World Health Organization; 2002.No.2.
3. Saeidnia S, Yassa N, Rezaeipoor R, Shafiee A, Gohari AR, Kamalinejad M, et al. Immunosuppressive principles from Achillea talagonica, an endemic species of Iran. Daru 2009; 17:37-41.
4. Benedek B, Kopp B, Melzig MF. Achillea millefolium L. s.l. is the anti-inflammatory activity mediated by protease inhibition? J Ethnopharmacol 2007; 113:312-317.
5. Candan F, Unlu M, Tepe B, Daferera D, Polissiou M, Sokmen A, Akpulat HA. Antioxidant and antimicrobial activity of the essential oil and methanol extracts of Achillea millefolium subsp. millefolium Afan. (Asteraceae). J Ethnopharmacol 2003; 87:215-220.
6. Stojanovic G, Radulovic N, Hashimoto T, Palic R. In vitro antimicrobial activity of extracts of four Achillea species: the composition of Achillea clavennae L. (Asteraceae) extract. J Ethnopharmacol 2005; 101:185-190.
7. Asgary S, Naderi GH, Sarrafzadegan N, Mohammadifard N, Mostafavi S, Vakili R. Antihypertensive and antihyperlipidemic effects of Achillea wilhelmsii. Drugs Exp Clin Res 2000; 26:89-93.
8. Tozyo T, Yoshimura Y, Sakurai K, Uchida N, Takeda Y, Nakai H, et al. Antitumor sesquiterpenoids in Achillea millefolium. Chem Pharm Bull (Tokyo) 1994; 42:1096-100.
9. Csupor-Löffler B, Hajdú Z, Zupkó I, Réthy B, Falkay G, Forgo P, et al. Antiproliferative effect of flavonoids and sesquiterpenoids from Achillea millefolium s.l. on cultured human tumour cell lines. Phytother Res 2009; 23:672-676.
10. Nemeth E, Bernath J. Biological activities of yarrow species (Achillea spp.). Curr Pharm Des 2008; 14:3151-3167.
11. Lemmens-Gruber R, Marchart E, Rawnduzi P, Engel N, Benedek B, Kopp B. Investigation of the spasmolytic activity of the flavonoid fraction of Achillea millefolium s.l. on isolated guinea-pig ilea. Arzneimittelforschung 2006; 56:582-588.
12. Yaeesh S, Jamal Q ,Khan AU, Gilani AH. Studies on hepatoprotective, antispasmodic and calcium antagonist activities of the aqueous-methanol extract of Achillea millefolium. Phytother Res 2006; 20:546-551.
13. Karamenderes C, Apaydin S. Antispasmodic effect of Achillea nobilis L. subsp. sipylea (O. Schwarz) Bässler on the rat isolated duodenum. J Ethnopharmacol 2003; 84:175-179.
14. Benedek B, Geisz N, Jager W, Thalhammer T, Kopp B. Choleretic effects of yarrow (Achillea millefolium s.l.) in the isolated perfused rat liver. Phytomedicine 2006; 13:702-706.
15. Cavalcanti AM, Baggio CH, Freitas CS, Rieck L, de Sousa RS, Da Silva-Santos JE, et al. Safety and antiulcer efficacy studies of Achillea millefolium L. after chronic treatment in Wistar rats. J Ethnopharmacol 2006; 107:277-2784.
16. Mahady GB, Pendland SL, Stoia A, Hamill FA, Fabricant D, Dietz BM, et al. In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother Res 2005; 19:988-9891.
17. Dokhani S, Cottrell T, Khajeddin J, Mazza G. Analysis of aroma and phenolic components of selected Achillea species. Plant Foods Hum Nutr 2005; 60:55-62.
18. Afsharypuor S, Asgary S, Lockwood GB. Constituents of the essential oil of Achillea wilhelmsii from Iran. Planta Med 1996; 62:87-78.
19. Gherase F, Spac A, Dorneanu V, Stănescu U, Grigorescu E. Pharmacognostic research of some species of Achillea. Note 1. Volatile oils analysis. Rev Med Chir Soc Med Nat Iasi 2003; 107:188-191. (Article in Romanian)
20. Javidian K, Miri R, Sadeghpour H. Compsition of the volatile oil of Achillea wilhelmsii C. Koch from Iran. Daru 2004; 12:63-66.
21. Nabavizadeh Rafsanjani F, Vahedian J. The effect of insulin-dependent diabetes mellitus on basal and distention-induced gastric acid and pepsin secretion in rat. Diabetes Res Clin Pract 2004; 66:1-6.
22. Niazmand S, Hosaini KH, Derakhshan M. The effects of Ziziphora clinopodioides Lam. extract on rat’s gastric motility at basal and vagal stimulated conditions.Pharmacologyonline (newsletter) 2009; 2:734-740
23. Rotondo A, Serio R, Mulè F. Gastric relaxation induced by apigenin and quercetin: analysis of the mechanism of action. Life Sci 2009; 85:85-90.
24. Wells RW, Lourenssen S, Blennerhassett MG. Impaired acetylcholine-induced smooth muscle contraction in colitis involves altered calcium mobilization and AKT phosphorylation. Pflugers Arch 2008; 456:507-517.
25. Bergner A, Sanderson MJ. Acetylcholine-induced calcium signaling and contraction of airway smooth muscle cells in lung slices. J Gen Physiol 2002; 119:187-198.